Evidence map›Paper›PMID 40705371›Full record

ArticleEmerging infectious diseases2025

Community-Scale Surveillance of SARS-CoV-2 and Influenza A Viruses in Wild Mammals, United States, 2022-2023.

Grete Wilson-Henjum, J Jeffrey Root, Alex Worgo, Jeffrey Chandler, Robin Dyer, Jeff Flores, Jesse Morris, Ian Plummer, John Paul Seman, Kyle Van Why and 11 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Grete Wilson-Henjum
J Jeffrey Root
Alex Worgo
Jeffrey Chandler
Robin Dyer
Jeff Flores
Jesse Morris
Ian Plummer
John Paul Seman
Kyle Van Why
Caleb Wellman
H Bryant White
John Wilt
Diego Diel
Jon Heale
David L Bergman
Josh Hewitt
Derek Collins
Ryan S Miller
Steven Rekant
Kim M Pepin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sampling of mammal communities across the United States during 2022-2023 detected evidence of SARS-CoV-2 antibodies in 3 new species and 2 previously described species and evidence of influenza A antibodies in 2 previously described species. Our analysis provides surveillance and sampling guidance for detection of rare exposure events.

Indexed as

Animals, WildCOVID-19Influenza A virusMammalsOrthomyxoviridae InfectionsSARS-CoV-2AnimalsAntibodies, ViralEpidemiological MonitoringHumansUnited StatesAntibodies, Viraldetectioninfluenzainfluenza Arespiratory infectionsSARS-CoV-2surveillanceUnited Statesviruseswildlife communityzoonoses

Identifiers

PMID40705371
PMCPMC12309772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.